{"id":1142,"date":"2020-03-10T14:29:23","date_gmt":"2020-03-10T13:29:23","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=1142"},"modified":"2021-10-07T17:08:20","modified_gmt":"2021-10-07T15:08:20","slug":"991-2","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/991-2\/","title":{"rendered":"COVID-19: Recomendaciones para empresas y personas trabajadoras"},"content":{"rendered":"<p>El pasado lunes y hoy se ha reunido el Consejo de Relaciones Laborales -\u00f3rgano estable de concertaci\u00f3n social formato por el Departamento de Trabajo, Asuntos Sociales y Familias, Fomento del Trabajo Nacional,\u00a0Pimec, CCOO de Catalu\u00f1a y UGT de Catalu\u00f1a- para acordar un documento de recomendaciones para empresas y personas trabajadoras sobre el\u00a0coronavirus\u00a0SARS-*COV-2.<\/p>\n<p>Puedes acceder al documento mediante este enlace:<\/p>\n<p><a href=\"https:\/\/www.ccoo.cat\/pdf_documents\/2020\/Recomanacions_CRL_sobre_SARS-COV-2_9_03_2020.pdf\"><span style=\"color: #0000ff\"><strong>RECOMENDACIONES PARA EMPRESAS Y PERSONAS <\/strong><\/span><span style=\"color: #0000ff\"><strong>TRABAJADORAS<\/strong><\/span><\/a>    \t    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pasado lunes y hoy se ha reunido el Consejo de Relaciones Laborales -\u00f3rgano estable de concertaci\u00f3n social formato por el Departamento de Trabajo, Asuntos Sociales y Familias, Fomento del &#8230; <a title=\"COVID-19: Recomendaciones para empresas y personas trabajadoras\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/991-2\/\" aria-label=\"Leer m\u00e1s sobre COVID-19: Recomendaciones para empresas y personas trabajadoras\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":1137,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-1142","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notesinformatives","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=1142"}],"version-history":[{"count":1,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1142\/revisions"}],"predecessor-version":[{"id":4756,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/1142\/revisions\/4756"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/1137"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=1142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=1142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=1142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}